Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to perform so might be grounds for compensation. Our lawyers are functioning challenging to obtain those hurt by the drug the compensation they are entitled to.













Whilst bleeding is actually a typical complication linked with anticoagulants, it has been alleged that Xarelto is far more harmful than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, individuals could be at risk for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.













If you or perhaps a loved one particular suffered a significant bleeding event following taking Xarelto, you may have legal recourse. For much more information, contact us today to possess your case reviewed, totally free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in situations of death, funeral costs. Additionally, they may be seeking punitive damages, that are normally awarded to punish the defendant and deter other businesses from acting similarly.






Why Are Lawsuits Becoming Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several xarelto when to stop heparin lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a protected anticoagulant option.






Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.






Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.













Visit this page for much more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki